THERAPEUTICS AND CLINICAL RISK MANAGEMENT, cilt.14, ss.1369-1377, 2018 (SCI-Expanded)
Background: Data regarding lacosamide treatment as an adjunctive therapy in patients representative of a focal-onset epilepsy population including those with and without intellectual/ developmental disorders (IDDs) arc limited.